Drug intelligence / Profile preview

Arth-90

Development stage: Unknown
Lead developer: Cam Neuro Pharma
Modality: Small Molecules
Administration: Oral

Overview

Arth-90 is a multi-ingredient nutraceutical supplement formulated as an oral syrup, developed and marketed by Cam Neuro Pharma. It contains a combination of antioxidants and botanical extracts, specifically lycopene, grape seed extract, ginseng, and a blend of vitamins. The product is positioned for joint health support and general antioxidant protection, aiming to mitigate oxidative stress and support overall wellness. As a marketed supplement in India, it serves as a supportive therapy rather than a primary treatment for specific diseases, leveraging the adaptogenic properties of ginseng and the free-radical scavenging capabilities of its antioxidant components.

Brand names: Arth-90Arth90Arth 90
Other names: Arth 90Arth90Arth-90Lycopene + Grape Seed Extract + Ginseng + vitamins syrup

Beyond the preview

Go deeper on Arth-90.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arth-90.

Explore the full profile